Skip to content
Tuesday, November 17, 2026
Digital Pulse

Zimbabwe Rejects ‘One-Sided’ US Healthcare Assistance Agreement Over Information Concerns

Medical aid illustration
The proposed US funding was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has declined a significant American health deal worth 367 million US dollars (£272m) over five years over the United States' demand for sensitive biological samples.

This move came to light following a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".

An official spokesperson later stated that the US was demanding access to health data for research and profit but was unwilling to share the benefits from any future medical innovations.

"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has appealed for more negotiations to secure a agreement suitable to both sides so the nation's vital HIV programme can continue.

Wider Context

This rejection follows a comparable situation in neighbouring Kenya, where a court halted a related deal with the US after legal challenges were filed about the security of citizens' health data.

After resuming office last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.

The agency had administered assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance transparency and responsibility.

According to reports, Sixteen nations in Africa have to date signed similar agreements, representing over $18.3bn in new funding.

Details of the Rejected Deal

This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment through American-funded initiatives," Tremont commented.

However, official spokesman Nick Mangwana said the arrangement was "unequal".

"Zimbabwe was being asked to share its genetic material and health information indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," he stated.

"Put simply, our nation would provide the basic resources for medical research without any certainty that the end products would be accessible to our population if a future health crisis emerge."

National Interest and Global Health

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining frameworks already set up via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with potential pandemics.

"This framework is designed to guarantee that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."

These objections regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We welcome ongoing discussions with our American counterparts on how subsequent collaboration might be arranged in a manner that respects the independence and interests of both nations."

Health Experts Reaction

Medical experts said it acknowledged the official position, but urged that negotiations need to persist considering much of the country's Aids initiatives relied on external financing.

"In cases where technical issues arise, such as those relating to data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group added.

The halted deal highlights the ongoing challenges between receiving crucial foreign assistance and protecting a country's data in an ever more interconnected world.

The writer

Charles Bruce

A tech enthusiast and digital strategist with over a decade of experience in web development and emerging technologies.

Digital Pulse

Type to search articles.